VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 8, 2026
Stock Comparison
Brookfield Asset Management Ltd. vs Johnson & Johnson
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Brookfield Asset Management Ltd.
BAM · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Brookfield Asset Management Ltd.'s moat claims, evidence, and risks.
View BAM analysisJohnson & Johnson
JNJ · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Johnson & Johnson's moat claims, evidence, and risks.
View JNJ analysisComparison highlights
- Moat score gap: Brookfield Asset Management Ltd. leads (75 / 100 vs 61 / 100 for Johnson & Johnson).
- Segment focus: Brookfield Asset Management Ltd. has 5 segments (30.3% in Credit); Johnson & Johnson has 2 segments (64.1% in Innovative Medicine).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
- Moat breadth: Brookfield Asset Management Ltd. has 4 moat types across 2 domains; Johnson & Johnson has 5 across 3.
Primary market context
Brookfield Asset Management Ltd.
Credit
Private credit, opportunistic credit, and multi-strategy credit asset management
Global
Institutional investors, insurance accounts, and private wealth investors
Alternative credit manager / asset manager
30.3%
Johnson & Johnson
Innovative Medicine
Branded prescription pharmaceuticals (biopharma)
Global
Wholesalers, hospitals, retailers, healthcare professionals, payers
Drug discovery, development, manufacturing, commercialization
64.1%
Side-by-side metrics
Moat coverage
Shared moat types
Brookfield Asset Management Ltd. strengths
Johnson & Johnson strengths
Segment mix
Brookfield Asset Management Ltd. segments
Full profile >Renewable Power and Transition
Oligopoly
Infrastructure
Oligopoly
Real Estate
Oligopoly
Private Equity
Oligopoly
Credit
Oligopoly
Johnson & Johnson segments
Full profile >Innovative Medicine
Competitive
MedTech
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.